FDA Drug Application (021992) for PRISTIQ by WYETH PHARMS INC

Back to FDA Applications sponsored by WYETH PHARMS INC

Application Number021992
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 50MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePRISTIQ
Active IngredientDESVENLAFAXINE SUCCINATE

Active IngredientCount
List of drugs with Active Ingredient DESVENLAFAXINE SUCCINATE2


Back to FDA Applications sponsored by WYETH PHARMS INC